sur Frequency Exchange Corp. (isin : CA3580191078)
Frequency Exchange Corp. Highlights Success at ECO24 Event
Frequency Exchange Corp., through its subsidiary FREmedica Technologies Inc., successfully presented at the ECO24 Event in Dallas, Texas. This event, hosted by CellCore Biosciences, is notable for gathering 1,500 professionals focused on frequency and Lyme disease management. FREmedica introduced its product NIKKI, a personal Frequency Delivery System, to an enthusiastic audience of health experts. The presentation received positive feedback, facilitating numerous affiliations and financial involvement from attending practitioners.
Stephen Davis, CEO of Frequency Exchange Corp., expressed gratitude towards the CellCore team and the doctors present. He commended the event for its familial atmosphere and the collaborative spirit it fostered. The successful demonstration of NIKKI, which targets wellness and Lyme disease management, marked a significant milestone for the company at this prestigious annual meeting.
R. P.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Frequency Exchange Corp.